No Prescription |
 |
 | ||
|
METROGYL Flagyl |
|
| ||
No Prescription » Prescription Drugs 11 » METROGYL Flagyl Metronidazole eliminates bacteria and other microorganisms that cause infections of the reproductive system gastrointestinal tract skin vagina and other areas of the body. Antibiotics will not work for colds flu or other viral infections.Metronidazole comes as a tablet to take by mouth. It is usually taken two or three times a day for 5-10 days or longer. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Take metronidazole exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor. Buy METROGYL Flagyl and other Prescription Drugs 11 products online at Medstore. Buy Online at Medstore - Click Here!
About METROGYL Flagyl: Product Type: Prescription Drugs 11 METROGYL ( Flagyl Generic Metronidazole ) METROGYL (Flagyl Generic Metronidazole) Flagyl Generic Metronidazole 200mg 100 Tablets 200mg 200(2 x 100) Tablets 200mg 400(4 x 100) Tablets 400mg 200(2 x 100) Tablets 400mg 400(4 x 100) Tablets 400mg 100 Tablets Flagyl Generic Metronidazole METROGYL
View more Prescription Drugs 11 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
